News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Northern Dynasty Stock Melts Down: Here's Why
Finviz·2026/02/18 18:42
Fusion Fuel Expands Clean Energy Reach Via Royal Uranium Acquisition
Finviz·2026/02/18 18:39
Wall Street Moves Into XRP: Franklin Templeton ETF Crosses $200M in Assets
Coinpedia·2026/02/18 18:30
Cardano Bounces, But Bearish Structure Remains—Can the Bulls Push ADA Price to $0.5
Coinpedia·2026/02/18 18:30
WLFI Price Jumps 25% as Mar-a-Lago Event Hype Ignites Futures Frenzy
Coinpedia·2026/02/18 18:30
The XRP Flywheel Effect: Why Price Discovery May Become Inevitable as Corridors Flip
Coinpedia·2026/02/18 18:30
Is Litecoin’s (LTC) Price Rally Over—Or Is a Surprise Breakout Coming?
Coinpedia·2026/02/18 18:30
How Much Bitcoin Is Left to Buy? Real Supply Is Below 21 Million
Coinpedia·2026/02/18 18:30
Bitcoin Dominance Weakens as Ethereum Gains Momentum, Analysts Say
BlockchainReporter·2026/02/18 18:27
Starfighters Space (FJET) Shares Soar As Space Stocks Rebound
Finviz·2026/02/18 18:24
Flash
08:41
Market focuses on peace talks between the US and Iran, gold prices decline```htmlGolden Ten Data reported on June 29 that Mitsubishi UFJ analyst Soojin Kim pointed out that as the market focus shifts to easing inflation expectations and the prospect of renewed peace talks between Iran and the United States, gold prices have declined. She added: "As the geopolitical risk premium continues to fade and energy-driven inflation expectations improve, gold prices may remain under pressure." Previously, Iran and the United States had exchanged fire but subsequently agreed to stop hostile actions.```
08:38
Battery technology company Solidion: Will purchase SpaceX shares as strategic reserve assetsBlockBeats news, on June 29, battery technology company Solidion Technology announced it will purchase shares of a certain exchange as a strategic reserve asset.
08:38
Viridian Therapeutics shares surged 10.8% in pre-market trading after its drug for treating thyroid eye disease received approval from the U.S. Food and Drug Administration.This regulatory green light paves the way for the commercialization of the company's core product line, marking a key breakthrough in addressing this autoimmune disease. The market responded positively to this news, and investor sentiment was significantly boosted.
News